Fig. 7
From: Integrative analysis of time course metabolic data and biomarker discovery
Posterior distributions of Ï•e for each pathway for each treatment group for the metformin dataset. Posterior distributions of Ï•e for some pathways are flatter for the controls than the cases which might be indicative mild pathway alterations. These pathways correspond as well to the top 11 pathways inferred by MetaboAnalyst [30]. The p-values are the p-values returned by MetaboAnalyst for each pathway